During the past decade, Nanjing Brain Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nanjing Brain Hospital" #1 sponsor was "Nanjing Medical University" with 5 trials, followed by "Peking University" with 3 trials sponsored, "Shanghai Mental Health Center" with 3 trials sponsored, "Sumitomo Pharma (Suzhou) Co., Ltd." with 3 trials sponsored and "Biohaven Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nanjing Brain Hospital" #1 collaborator was "Beijing Novartis Pharma" with 1 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator, "BioShin Limited" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Capital Medical University" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Nanjing Brain Hospital" are "Depression" (3 trials), "Schizophrenia" (3 trials), "Acute Ischemic Stroke" (2 trials), "Dementia" (2 trials) and "Major Depressive Disorder" (2 trials). Many other conditions were trialed in "Nanjing Brain Hospital" in a lesser frequency.

Most popular intervention types in "Nanjing Brain Hospital" are "Drug" (21 trials), "Behavioral" (5 trials), "Device" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Compound Edaravone Injection" (2 trials), "Edaravone Injection" (2 trials), "SSRI antidepressants" (2 trials) and "Active rTMS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nanjing Brain Hospital" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Nanjing Brain Hospital". 1 are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Nanjing Brain Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nanjing Brain Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".